I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…
During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…
ESCOs are accountable for clinical quality outcomes and financial outcomes.
CMS also has upcoming plans to impose fiscal penalties related to dialysis treatment.
Patient-centeredness should become a core component of clinical practice guidelines, according to Dr Kalantar-Zadeh.
A number of patients referred to my faculty ambulatory clinic at the University of California Irvine have urologic disorders, including some who underwent partial or radical nephrectomy. Many patients do not comprehend the distinction between nephrologist and urologist, and refer to both as “kidney doctor.” I often educate these patients, explaining that a urologist is…
The guidelines state that clinicians should offer blue light cystoscopy, if available, as an adjunct to traditional white light cystoscopy (WLC) to increase tumor detection and decrease recurrence.
To avoid CKD, the guidelines now provide detailed review of the risk/benefit profile comparing partial to radical nephrectomy.
Both urologists and nephrologists provide follow-up and continuity of care to patients after cancer nephrectomy.
Data from MagnaSafe suggest that MRIs for patients with pacemakers/ICDs can be performed safely.
